scispace - formally typeset
J

Jeong Chan Ra

Researcher at Seoul National University

Publications -  40
Citations -  1697

Jeong Chan Ra is an academic researcher from Seoul National University. The author has contributed to research in topics: Stem cell & Mesenchymal stem cell. The author has an hindex of 15, co-authored 40 publications receiving 1475 citations.

Papers
More filters
Journal ArticleDOI

Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans.

TL;DR: The systemic transplantation of hAdMSCs appears to be safe and does not induce tumor development, according to a human clinical trial and a tumorigenicity test in mice.
Journal ArticleDOI

Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy.

TL;DR: This review of the state of current research on homing of MSCs suggests that favorable cellular conditions and the in vivo environment facilitate and are required for the migration of M SCs to the site of insult or injury in vivo.
Journal ArticleDOI

Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells

TL;DR: The improvement in cell proliferation and differentiation using Oct4/Sox2 expression in ATMSCs may be a useful method for expanding the population and increasing the stemness of AT MSCs.
Journal ArticleDOI

Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells.

TL;DR: The data provide convincing evidence for safety and therapeutic properties of systemically administered AdMSC in human patients with no other treatment options, and the authors believe that ex-vivo-expanded autologous AdMSCs provide a promising alternative for treating autoimmune diseases.
Journal ArticleDOI

Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation.

TL;DR: Serial human AD-MSC transplantation had beneficial effects in the treatment of SLE, without adverse effects, and before disease onset was preferable for amelioration of Sle and restoration of immune homeostasis.